Published in J Virol on November 14, 2012
Deep mutational scanning: a new style of protein science. Nat Methods (2014) 2.05
Deep sequencing: becoming a critical tool in clinical virology. J Clin Virol (2014) 1.07
Measuring the activity of protein variants on a large scale using deep mutational scanning. Nat Protoc (2014) 1.07
Dissecting enzyme function with microfluidic-based deep mutational scanning. Proc Natl Acad Sci U S A (2015) 1.05
High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution. Sci Rep (2014) 1.03
A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivity. PLoS Pathog (2014) 0.99
Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study. PLoS Comput Biol (2014) 0.96
Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses. Nat Commun (2014) 0.91
Systematic Mapping of Protein Mutational Space by Prolonged Drift Reveals the Deleterious Effects of Seemingly Neutral Mutations. PLoS Comput Biol (2015) 0.88
Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y. Antimicrob Agents Chemother (2014) 0.88
High-throughput profiling of point mutations across the HIV-1 genome. Retrovirology (2014) 0.87
High-throughput identification of loss-of-function mutations for anti-interferon activity in the influenza A virus NS segment. J Virol (2014) 0.87
HIV-1 quasispecies delineation by tag linkage deep sequencing. PLoS One (2014) 0.86
Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality. PLoS Genet (2015) 0.85
Coupling high-throughput genetics with phylogenetic information reveals an epistatic interaction on the influenza A virus M segment. BMC Genomics (2016) 0.80
Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome. PLoS One (2015) 0.79
Exploring the functional residues in a flavin-binding fluorescent protein using deep mutational scanning. PLoS One (2014) 0.78
Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates. Virology (2015) 0.76
A Statistical Guide to the Design of Deep Mutational Scanning Experiments. Genetics (2016) 0.76
Predicting the combined effect of multiple genetic variants. Hum Genomics (2015) 0.75
The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir. J Mol Biol (2015) 0.75
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature (2005) 11.99
The influenza virus resource at the National Center for Biotechnology Information. J Virol (2007) 11.33
Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal Biochem (1979) 7.09
Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science (2010) 5.94
Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol (2005) 5.48
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48
Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol (2002) 5.09
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res (2002) 4.85
Global transmission of oseltamivir-resistant influenza. N Engl J Med (2009) 4.34
Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature (2010) 3.95
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature (2008) 3.79
High-resolution mapping of protein sequence-function relationships. Nat Methods (2010) 3.47
Quasispecies theory and the behavior of RNA viruses. PLoS Pathog (2010) 3.19
Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe (2010) 3.13
Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses (2012) 3.04
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis (2006) 2.76
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog (2008) 2.49
Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet (2011) 2.41
Influenza: propagation, quantification, and storage. Curr Protoc Microbiol (2006) 2.36
Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc Natl Acad Sci U S A (2008) 2.15
The essential genome of a bacterium. Mol Syst Biol (2011) 2.14
Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A (2011) 2.04
Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes. Nat Protoc (2007) 1.97
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog (2010) 1.81
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog (2010) 1.65
Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design. Curr Opin Biotechnol (2005) 1.64
Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. Curr Med Chem (2000) 1.38
Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe (2009) 1.30
High-resolution functional profiling of hepatitis C virus genome. PLoS Pathog (2008) 1.30
A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS One (2011) 1.16
Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses. PLoS Pathog (2011) 1.14
Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J Virol (2011) 1.14
Maximizing the value of drug stockpiles for pandemic influenza. Emerg Infect Dis (2009) 1.08
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675. J Virol (2002) 1.04
Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness. J Antimicrob Chemother (2010) 1.03
Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1. J Clin Virol (2011) 0.99
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours. Emerg Infect Dis (2010) 0.96
High-resolution functional mapping of the venezuelan equine encephalitis virus genome by insertional mutagenesis and massively parallel sequencing. PLoS Pathog (2010) 0.89
IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity (2002) 6.85
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst (2003) 3.09
Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm. Proc Natl Acad Sci U S A (2008) 2.22
NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol (2003) 2.15
Fluorescent imaging of single nanoparticles and viruses on a smart phone. ACS Nano (2013) 2.14
Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc Natl Acad Sci U S A (2005) 1.98
Transcription program of murine gammaherpesvirus 68. J Virol (2003) 1.96
Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol (2002) 1.83
Identification of proteins associated with murine gammaherpesvirus 68 virions. J Virol (2003) 1.75
Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe (2007) 1.71
Three-dimensional visualization of gammaherpesvirus life cycle in host cells by electron tomography. Structure (2010) 1.65
The value of avian genomics to the conservation of wildlife. BMC Genomics (2009) 1.63
Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol (2002) 1.60
Quantitative imaging of single, unstained viruses with coherent x rays. Phys Rev Lett (2008) 1.52
Arrangement of core membrane segments in the MotA/MotB proton-channel complex of Escherichia coli. Biochemistry (2004) 1.45
Murine gammaherpesvirus 68 open reading frame 31 is required for viral replication. J Virol (2004) 1.40
Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk. Tumour Biol (2013) 1.39
Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol (2003) 1.36
Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo. J Virol (2008) 1.36
MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep (2010) 1.34
Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog (2007) 1.32
Viral Bcl-2-mediated evasion of autophagy aids chronic infection of gammaherpesvirus 68. PLoS Pathog (2009) 1.31
Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene (2003) 1.31
Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe (2009) 1.30
High-resolution functional profiling of hepatitis C virus genome. PLoS Pathog (2008) 1.30
Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet (2011) 1.26
ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J Virol (2006) 1.24
The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology (2009) 1.21
Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood (2002) 1.20
B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett (2007) 1.16
ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J Virol (2008) 1.14
Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog (2010) 1.14
Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes. ACS Nano (2009) 1.14
Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68. J Virol (2004) 1.13
Substituted 2-pyrrolinone inhibitors of HIV-1 integrase. Bioorg Med Chem Lett (2007) 1.11
Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J Virol (2007) 1.11
Microfluidic device architecture for electrochemical patterning and detection of multiple DNA sequences. Langmuir (2008) 1.09
Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol (2005) 1.09
Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics. J Am Chem Soc (2011) 1.09
Inhibition of gammaherpesvirus replication by RNA interference. J Virol (2003) 1.08
beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA. J Virol (2005) 1.08
Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J Virol (2010) 1.08
mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin. ACS Chem Biol (2008) 1.07
Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J Virol (2010) 1.05
TANK-binding kinase-1 plays an important role during in vitro and in vivo type I IFN responses to DNA virus infections. J Immunol (2009) 1.04
Murine gammaherpesvirus 68 open reading frame 45 plays an essential role during the immediate-early phase of viral replication. J Virol (2005) 1.04
A repetitive region of gammaherpesvirus genomic DNA is a ligand for induction of type I interferon. J Virol (2007) 1.02
Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res (2009) 1.02
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore. Bioorg Med Chem (2007) 1.02
Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus. Antivir Ther (2005) 1.02
Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology (2002) 1.01
Murine gammaherpesvirus 68 ORF52 encodes a tegument protein required for virion morphogenesis in the cytoplasm. J Virol (2007) 1.00
Systematic quantitative characterization of cellular responses induced by multiple signals. BMC Syst Biol (2011) 0.99
A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein. PLoS Pathog (2007) 0.99
HIV-1 integrase inhibitors: 2005-2006 update. Med Res Rev (2008) 0.99
On-chip cytometry using plasmonic nanoparticle enhanced lensfree holography. Sci Rep (2013) 0.99
From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes. J Med Chem (2006) 0.99
Single-round, multiplexed antibody mimetic design through mRNA display. Angew Chem Int Ed Engl (2012) 0.98
Generation of a latency-deficient gammaherpesvirus that is protective against secondary infection. J Virol (2004) 0.98
COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression. J Virol (2003) 0.98
Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs. Integr Biol (Camb) (2009) 0.98
Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer. Mol Cancer Ther (2013) 0.97
Fate modeling of phenanthrene with regional variation in Tianjin, China. Environ Sci Technol (2003) 0.97
A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity. J Immunol (2007) 0.97
Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta. Virology (2006) 0.96
Unique structures in a tumor herpesvirus revealed by cryo-electron tomography and microscopy. J Struct Biol (2007) 0.96
Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency. J Gen Virol (2009) 0.94
CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehav HIV Med (2009) 0.93
Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma. Int J Med Sci (2013) 0.93
Unconventional sequence requirement for viral late gene core promoters of murine gammaherpesvirus 68. J Virol (2014) 0.92
Distinct domains in ORF52 tegument protein mediate essential functions in murine gammaherpesvirus 68 virion tegumentation and secondary envelopment. J Virol (2011) 0.92
mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein. J Biol Chem (2009) 0.92
Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency. J Virol (2010) 0.92
An integrated approach to elucidate the intra-viral and viral-cellular protein interaction networks of a gamma-herpesvirus. PLoS Pathog (2011) 0.91
Construction and characterization of an infectious murine gammaherpesivrus-68 bacterial artificial chromosome. J Biomed Biotechnol (2010) 0.91
The anti-interferon activity of conserved viral dUTPase ORF54 is essential for an effective MHV-68 infection. PLoS Pathog (2011) 0.91